IMVARIA helps patients with interstitial lung disease and idiopathic pulmonary fibrosis
MedTech Alum ‘21 IMVARIA brings artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious lung diseases. Fibresolve and ScreenDx are the first FDA-authorized tools in interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF). ScreenDx uses AI to... Read More →